Greystone Pharmaceuticals, Inc. is dedicated to bringing its patented platform of wound care technologies to the global marketplace, using them to improve quality of life and healthcare outcomes for patients who suffer from chronic wounds, and to lower healthcare costs associated with chronic wound treatment.
